| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACAD | Common Stock | Award | $0 | +34,666 | +34% | $0.000000 | 136,556 | 25 Mar 2024 | Direct | F1 |
| transaction | ACAD | Common Stock | Sale | $317,081 | -17,714 | -13% | $17.90 | 118,842 | 27 Mar 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACAD | Stock Option (Right to Buy) | Award | $0 | +286,451 | $0.000000 | 286,451 | 25 Mar 2024 | Common Stock | 286,451 | $17.84 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents acquisition of the Issuer's common stock upon vesting of the performance stock units granted to the Reporting Person on April 5, 2022 at 50% of target. |
| F2 | The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of performance stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). |
| F3 | 25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2025. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter. |